Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 387 clinical trials in Maastricht, The Netherlands across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
BelgiumStudy on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease
BelgiumStudy of reduced pembrolizumab dosing compared to standard dose in patients with advanced non-small cell lung cancer
The NetherlandsStudy of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation
AustriaStudy on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy
The NetherlandsStudy Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma
The NetherlandsStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
GermanyStudy on Early Discontinuation of Nivolumab and Ipilimumab in Patients with Advanced Melanoma
The NetherlandsStudy on Low Dose Acetylsalicylic Acid to Prevent Preeclampsia in Pregnant Women After Frozen Embryo Transfer
BelgiumStudy Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
The NetherlandsStudy on Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed High-Risk Multiple Myeloma Patients
GermanyStudy on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, breast cancer, and melanoma treatments. Studies include novel therapy combinations and personalized treatment approaches.
Particular emphasis on targeted therapies and treatment optimization for various cancer types.
Research focusing on chronic kidney disease, fibromyalgia, and inflammatory bowel conditions. Studies evaluate new therapeutic approaches and treatment combinations.
Emphasis on developing effective long-term management strategies for chronic conditions.
Investigations into peripheral arterial disease and cardiomyopathy treatments. Research includes innovative therapeutic approaches and preventive strategies.
Focus on improving patient outcomes through targeted interventions and preventive measures.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
